Placebo News and Research

RSS

Daily strawberry consumption could help reduce dementia risk for middle-aged individuals

New research from the University of Cincinnati found that daily strawberry consumption could help reduce the risk of dementia for certain middle-aged populations.

1 Nov 2023

Sweet truths: Could blackcurrant and citrus extracts help prevent type 2 diabetes?

In a recent study, European researchers found that blackcurrant (BC) extracts can lower blood sugar levels immediately after meals, but higher doses aren't more effective and fruit fibers don't boost the effect. Despite limitations, the study offers new directions for researching dietary interventions in managing type 2 diabetes and blood glucose levels.

1 Nov 2023

Spicing up memory: Wasabi found to boost brainpower in seniors

A 12-week study on adults over 60 found that wasabi supplements containing 6-MSITC significantly improved episodic and working memory. While other cognitive domains showed no improvement, the findings suggest that wasabi's anti-inflammatory and anti-oxidant properties may offer new avenues for combating age-related memory decline.

31 Oct 2023

New drug gets FDA approval for the treatment of common genetic disease in young boys

A new drug developed by professors from the School of Pharmacy and Pharmaceutical Sciences at Binghamton University has received Food and Drug Administration (FDA) approval for the treatment of patients with Duchenne muscular dystrophy (DMD), a common genetic disease that mostly affects young boys.

31 Oct 2023

Updated toolkit to guide global menopause care

Care for women with menopausal health issues should improve globally following the release of an updated Monash University-led toolkit that guides health professionals around the world in assessing and treating them.

30 Oct 2023

New drug candidate found to be highly effective in treating rare sight-threatening eye infection

A drug candidate, based on pioneering UCL and Moorfields Eye Hospital research and currently under development by SIFI S.p.A., has been found to be highly effective in treating a rare sight-threatening eye infection in a new international clinical trial.

26 Oct 2023

In acute myocardial infarction patients, does adding a traditional Chinese medicine compound to standard treatments improve outcomes?

Researchers investigated whether Tongxinluo, a Chinese medicinal compound, could improve clinical outcomes among ST-segment elevation myocardial infarction patients.

26 Oct 2023

Scientists achieve breakthrough in treating 'neglected' polymyalgia rheumatica

Scientists have found success in treating a 'neglected' inflammatory condition, polymyalgia rheumatica, with a drug that could provide an alternative to steroids for patients.

25 Oct 2023

Lack of direct comparisons prevents assessment of upadacitinib's benefit in Crohn's disease

Like several immunosuppressive biologics, the JAK inhibitor upadacitinib is also approved for the treatment of Crohn's disease. Commissioned by the Federal Joint Committee (G-BA), the Institute for Quality and Efficiency in Health Care (IQWiG) has now investigated in an early benefit assessment whether the drug offers an added benefit versus the appropriate comparator therapy to patients with moderate to severe active Crohn's disease who have had an inadequate response, lost response or are intolerant to conventional therapy or a biologic agent.

25 Oct 2023

Perioperative durvalumab may change standard-of-care for patients with resectable lung cancer

A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free survival (EFS) and pathologic complete response (pCR) rates compared to chemotherapy alone for patients with operable non-small cell lung cancer (NSCLC), according to results of a Phase III trial reported by researchers at The University of Texas MD Anderson Cancer Center.

24 Oct 2023

Intranasal vaccination: A potent one-time solution for comprehensive COVID-19 immunity

A single-dose intranasal vaccine effectively induces robust immune responses.

24 Oct 2023

Groundbreaking study reveals most effective adjunctive drug for Parkinson's disease

The efficacy, tolerability, and safety of various anti-Parkinson's drugs.

23 Oct 2023

Can strawberries mitigate Alzheimer's risk? Recent study suggests a possibility

Whether strawberry supplementation mitigates the risk for late-life dementia.

23 Oct 2023

Perioperative immunotherapy improves event-free survival in resectable early-stage lung cancer

Compared with pre-surgical (neoadjuvant) chemotherapy alone, adding perioperative immunotherapy – given before and after surgery – significantly improved event-free survival (EFS) in patients with resectable early-stage non-small cell lung cancer (NSCLC).

22 Oct 2023

Dual-action drug produces shows promising results in neuroendocrine tumor trial

A drug that simultaneously strikes cancer cells' growth circuits and pipeline to the bloodstream produced encouraging results in a clinical trial involving patients with advanced neuroendocrine tumors, according to a study led by Dana-Farber Cancer Institute investigators.

22 Oct 2023

Everolimus after surgery may benefit patients with very-high-risk clear cell renal cell carcinoma

A secondary analysis from the SWOG S0931 EVEREST trial has found that in the subgroup of patients with clear-cell renal cell carcinoma (RCC) who were at very-high risk of recurrence, those who were treated with everolimus after surgery had a statistically significant improvement in recurrence-free survival compared to patients getting placebo after surgery.

22 Oct 2023

Clinical study evaluates safety and efficacy of methylone in patients with severe PTSD

Clerkenwell Health, the modern mental health company specializing in matching patients with cutting-edge psychiatry treatments, today announced that it is taking part in Transcend Therapeutics’ Phase 2 study evaluating the safety and efficacy of methylone in patients with severe PTSD.

20 Oct 2023

Placebo News and Research

Daily strawberry consumption could help reduce dementia risk for middle-aged individuals

Sweet truths: Could blackcurrant and citrus extracts help prevent type 2 diabetes?

Spicing up memory: Wasabi found to boost brainpower in seniors

New drug gets FDA approval for the treatment of common genetic disease in young boys

Updated toolkit to guide global menopause care

New drug candidate found to be highly effective in treating rare sight-threatening eye infection

In acute myocardial infarction patients, does adding a traditional Chinese medicine compound to standard treatments improve outcomes?

Scientists achieve breakthrough in treating 'neglected' polymyalgia rheumatica

Lack of direct comparisons prevents assessment of upadacitinib's benefit in Crohn's disease

Perioperative durvalumab may change standard-of-care for patients with resectable lung cancer

Intranasal vaccination: A potent one-time solution for comprehensive COVID-19 immunity

Groundbreaking study reveals most effective adjunctive drug for Parkinson's disease

Can strawberries mitigate Alzheimer's risk? Recent study suggests a possibility

Perioperative immunotherapy improves event-free survival in resectable early-stage lung cancer

Dual-action drug produces shows promising results in neuroendocrine tumor trial

Everolimus after surgery may benefit patients with very-high-risk clear cell renal cell carcinoma

Clinical study evaluates safety and efficacy of methylone in patients with severe PTSD

Study finds more mature gut microbiome in malnourished Nigerien children after antibiotic treatment

Can selenium and vitamin E supplementation prevent recurrence and progression of non–muscle-invasive bladder cancer?

More antibiotics not better for preventing infection after joint replacement surgery, study finds

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News